DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program
- Global First: Bovine Avian Influenza Transmission to Humans Detected
- Potassium-Enriched Salt Substitutes: Reducing Blood Pressure Risk?
- Tritium Detection in Fukushima’s Seawater: Below Safety Standards
- What Reason Let AstraZeneca Withdraws COVID Vaccine From The Market?
- How Many Times Can a Cancer Patient Undergo Chemotherapy?
- What are the WHO recommendations for Japanese encephalitis vaccines?
DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program.
DARPA has announced its new Agents of Battlefield Care (ABC) program, which aims to develop a new combat anesthetic that can be applied to the wounded on the battlefield without requiring specialized medical training or complex monitoring instruments.
Like many everyday things, we take narcotics for granted so much that it’s hard to imagine a time when they didn’t exist. Anesthetics and the technologies that support them have made enormous life-saving advances since they were first developed in the 1840s, but not in the field of battlefield anesthetics, which are still not much better than a shot of morphine.
There are two reasons for this. The first reason is that anesthetics are not simply painkillers. They are a complex cocktail of drugs designed to perform a number of functions, including calming the patient, reducing pain perception, immobilizing the body or inducing a general state of anesthesia. A
dditionally, administering anesthesia requires specialist monitoring of the patient and providing support in the form of various gases and other mechanisms to stabilize breathing, keep oxygen levels in the green zone, and maintain heart function.
Another reason is that although anesthetics have been used hundreds of millions of times, no one really understands how they work. Doctors know how to use anesthetics, but they don’t know the mechanisms behind them.
DARPA’s goal in Project ABC is to solicit ideas on how to create a simpler, easier-to-apply battlefield anesthetic by looking at the problem at its fundamentals.
This new approach involves studying the mechanisms of anesthetics from the anatomical to the molecular level to untangle the “why” and develop a way to eliminate pain, allowing life-saving treatments to be administered as close as possible to the point of injury on the battlefield, Without the need for hospital-grade equipment and specialists or dangerous physiological side effects.
ABC program manager Michael Feasel said: “Battlefield care anesthesia is taking the risk out of a problem that, while targeting the U.S. Department of Defense, is disruptive to all of medicine.
It can make everything from rural emergency services to air medical services, First responders all the way to level one trauma centers benefit.
The program is designed to support the earlier adoption of life-saving interventions, closer to the point of injury, leading to better outcomes for all patients, whether combatants or civilians.”
DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.